Skip to main content
Premium Trial:

Request an Annual Quote

UPDATED: LabBook to Provide Tools to Two Research Groups

This article has been updated from a previous version.

NEW YORK, May 3 – LabBook announced two agreements Thursday to provide its informatics tools to academic institutions.

The first agreement, with the National Foundation for Cancer Research in Bethesda, Md., includes access to The Ohio State University Human Genome Database using LabBook’s Genome Query Engine and Genomic XML Browser. LabBook’s tools, which include desktop information retrieval, integration, mining, and visualization software, will be accessible to NFCR-sponsored researchers worldwide.

The OSU Human Genome Database is offered exclusively by LabBook, according to the company.

"It is the NFCR's goal to foster scientific collaboration and to create a global laboratory without walls,” NFCR president Franklin Salisbury Jr. said in a statement. “The partnership with LabBook provides the tools to our researchers so that they can pursue their research more efficiently." 

LabBook, which has offices in McLean, Va., and Columbus, Ohio, also announced Thursday an agreement with the Ohio Supercomputer Center to provide its XML-Life Sciences Solution to Ohio’s academic community.

“This collaboration will help foster the use of high-quality, time-saving bioinformatics software for our higher education institutions," OSC’s high performance computing division director, Al Stutz, said in a statement.

LabBook has been offering the XML-Life Sciences Solution to different groups since launching the software in January. The company has signed an agreement with John Wiley & Sons’ to make Wiley’s scientific content available through the XML browser.

In April, IBM also took an equity stake in LabBook as part of a strategic alliance to integrate its back-end data management, data integration and Internet infrastructure software with LabBook’s software. 

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.